Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.
Eur J Cancer
; 160: 72-79, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34785111
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasm, Residual
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Eur J Cancer
Year:
2022
Document type:
Article
Country of publication: